The effects of a computerized transfusion decision support system on physician compliance and its appropriateness for fresh frozen plasma use in a medical center

American Journal of Clinical Pathology

Volumn 135, Issue 3, 2011, Pages 417-422

  Chang, Chao Sung ^a,b   Lin, Yi Ching ^a   Wu, Yung Chao ^a   Yeh, Chi Jung ^a   Lin, Yu Chih ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Computerized transfusion decision support; Fresh frozen plasma use; Physician compliance; Transfusion

Indexed keywords

FRESH FROZEN PLASMA;

ARTICLE; BLOOD CLOTTING; COMPUTERIZED TRANSFUSION DECISION SUPPORT SYSTEM; DECISION SUPPORT SYSTEM; DOCTOR COMPLIANCE; EMERGENCY SURGERY; FEMALE; HEPATOBILIARY SYSTEM; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PLASMA TRANSFUSION; PLASMAPHERESIS; PRIORITY JOURNAL; THERAPY EFFECT; UNIVERSITY HOSPITAL; BLOOD BANK; BLOOD GROUP ABO SYSTEM; BLOOD TRANSFUSION; CLINICAL PRACTICE; COOPERATION; MANAGEMENT; METHODOLOGY; PHYSICIAN; PLASMA; RETROSPECTIVE STUDY; TAIWAN; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; ACADEMIC MEDICAL CENTERS; BLOOD BANKS; BLOOD TRANSFUSION; COOPERATIVE BEHAVIOR; DECISION SUPPORT SYSTEMS, CLINICAL; FEMALE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PLASMA; PRACTICE MANAGEMENT, MEDICAL; RETROSPECTIVE STUDIES; TAIWAN; TREATMENT OUTCOME;

EID: 79954451359     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP0ECFNHMGJ8EA     Document Type: Article

References (35)

1. Triulzi DJ. The art of plasma transfusion therapy. Transfusion. 2006;46:1268-1270. (Pubitemid 44117949)
2. Agence Française de Sécurité Sanitaire des Produits de Santé. Transfusion of fresh coagulated plasma: products, indications: general methods and recommendations [in French]. Transfus Clin Biol. 2002;9:322-332.
3. Crosby E, Ferguson D, Hume HA, et al. Guidelines for red blood cell and plasma transfusion for adults and children. Can Med Assoc J. 1997;156(Suppl):S1-12.
4. O'Shaughnessy DF, Atterbury C, Bolton MP. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004;126:11-28. (Pubitemid 38859478)
5. Alter HJ, Klein HG. The hazards of blood transfusion in historical perspective. Blood. 2008;112:2617-2626.
6. McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods. 21st ed. Philadelphia, PA: Saunders; 2006:677-679.
7. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25:573-577. (Pubitemid 16174471)
8. Goodnough LT, Brecher ME, Kanter MH, et al. Transfusion medicine: first of two parts: blood transfusion. N Engl J Med. 1999;340:438-447. (Pubitemid 29084776)
9. Corwin HL. Transfusion practice in the critically ill: can we do better [editorial]? Crit Care Med. 2005;33:232-233.
10. Hunt DL, Haynes RB, Hanna SE, et al. Effects of computerbased clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA. 1998;280:1339-1346. (Pubitemid 28473723)
11. Garg AX, Adhikari NK, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005;293:1223-1238. (Pubitemid 40327908)
12. Lin YC, Chang CS, Yeh CJ, et al. The appropriateness and physician compliance of platelet usage by a computerized transfusion decision support system in a medical center [published online ahead of print June 23, 2010]. Transfusion. 2010;50:2565-2570. doi: 10.1111/j.1537-2995.2010.02757.x.
13. Yeh CJ, Wu CF, Hsu WT, et al. Transfusion audit of fresh-frozen plasma in southern Taiwan. Vox Sang. 2006;91:270-274.
14. Chng WJ, Tan MK, Kuperan P. An audit of fresh frozen plasma usage in an acute general hospital in Singapore. Singapore Med J. 2003;44:574-578. (Pubitemid 38133496)
15. Chaudhary R, Singh H, Verma A, et al. Evaluation of fresh frozen plasma usage at a tertiary care hospital in North India. ANZ J Surg. 2005;75:573-576. (Pubitemid 41002564)
16. Iorio A, Basileo M, Marchesini E, et al. Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase. Blood Transfus. 2008;6:211-219.
17. Hsu HM, Lu CF, Lee SC, et al. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis. 1999;179:367-370.
18. Lin HH, Wang LY, Hu CT, et al. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol. 2003;69:471-474. (Pubitemid 36249859)
19. Sun CA, Chen HC, Lu CF, et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol. 1999;59:290-296.
20. Wang JT, Wang TH, Sheu JC, et al. Hepatitis C virus infection in volunteer blood donors in Taiwan: evaluation by hepatitis C antibody assays and the polymerase chain reaction. Arch Pathol Lab Med. 1993;117:152-156.
21. Beasley RP. Hepatitis B virus, the major etiology of hepatocellular carcinoma. Cancer. 1988;61:1942-1956.
22. Stanworth SJ, Brunskill SJ, Hyde CJ, et al. Is fresh frozen plasma clinically effective? a systematic review of randomized controlled trials. Br J Haematol. 2004;126:139-152. (Pubitemid 38859495)
23. Lerner RG, Nelson J, Sorcia E, et al. Evaluation of solvent/detergent- treated plasma in patients with a prolonged prothrombin time. Vox Sang. 2000;79:161-167.
24. Williamson LM, Llewelyn CA, Fisher NC, et al. A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion. 1999;39:1227-1234.
25. Kakkar N, Kaurt R, Dhanoa J. Improvement in fresh frozen plasma transfusion practice: results of an outcome audit. Transfus Med. 2004;14:231-235. (Pubitemid 38821562)
26. Ciavarella D, Reed RL, Counts RB, et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol. 1987;67:365-368. (Pubitemid 18022356)
27. McVay PA, Toy PTCY. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991;31:164-171.
28. Segal JB, Dzik WH; and the Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidencebased review. Transfusion. 2005;45:1413-1425. (Pubitemid 44194644)
29. Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci. 1981;26:388-393. (Pubitemid 11120724)
30. McGill DB. Predicting hemorrhage after liver biopsy. Dig Dis Sci. 1981;26:385-387. (Pubitemid 11120723)
31. Salem-Schatz SR, Avorn J, Soumerai SB. Influence of clinical knowledge, organizational context and practice style on transfusion decision making: implications for practice change strategies. JAMA. 1990;264:476-483. (Pubitemid 20223887)
32. Soutar RL, Jobanputra S, Tait RC. A two-phase audit of fresh frozen plasma: a regional approach [letter]. Transfus Med. 2004;14:75-76. (Pubitemid 38477762)
33. Liumbruno GM, Sodini ML, Grazzini G. Tuscan study on the appropriateness of fresh-frozen plasma transfusion (TuSAPlaT). Blood Transfus. 2007;5:75-84. (Pubitemid 352025998)
34. Tinmouth A, Macdougall L, Fergusson D, et al. Reducing the amount of blood transfusion: a systematic review of behavioral interventions to change physicians' transfusion practice. Arch Intern Med. 2005;165:845-852. (Pubitemid 40563229)
35. Eisenstaedt RS. Modifying physicians' transfusion practice. Transfusion Med. 1997;11:27-37. (Pubitemid 27083613)